| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Luigi Castaldo | Q89430817 |
| Giulia Graziani | Q49137204 | ||
| Luana Izzo | Q89402307 | ||
| P2093 | author name string | Alberto Ritieni | |
| Giovanni Di Minno | |||
| Anna Gaspari | |||
| Alfonso Narváez | |||
| P2860 | cites work | Contribution of Red Wine Consumption to Human Health Protection | Q89575076 |
| Compositional characterization study on high -molecular -mass polymeric polyphenols in red wines by chemical degradation | Q91718923 | ||
| Proanthocyanidin content as an astringency estimation tool and maturation index in red and white winemaking technology | Q91854876 | ||
| Wine and beer within a moderate alcohol intake is associated with higher levels of HDL-c and adiponectin | Q92059144 | ||
| Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease | Q92156078 | ||
| Pharmacological basis and new insights of resveratrol action in the cardiovascular system | Q92193955 | ||
| Effect of Grape Pomace Polyphenols With or Without Pectin on TMAO Serum Levels Assessed by LC/MS-Based Assay: A Preliminary Clinical Study on Overweight/Obese Subjects | Q92526514 | ||
| Wine and Health-New Evidence | Q93382044 | ||
| Review: dietary phenolic compounds, health benefits and bioaccessibility | Q95531543 | ||
| Wine polyphenols: potential agents in neuroprotection | Q21284967 | ||
| Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis | Q24617063 | ||
| Polyphenols, inflammation, and cardiovascular disease | Q24628815 | ||
| Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis | Q24648228 | ||
| Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease | Q26738450 | ||
| Molecular Properties of Red Wine Compounds and Cardiometabolic Benefits | Q26741941 | ||
| No interaction between alcohol consumption and HDL-related genes on HDL cholesterol levels | Q28280947 | ||
| Sorghum (Sorghum bicolor L.): Nutrients, bioactive compounds, and potential impact on human health | Q30244026 | ||
| Targeted and nontargeted wine analysis by (1)h NMR spectroscopy combined with multivariate statistical analysis. Differentiation of important parameters: grape variety, geographical origin, year of vintage | Q30627790 | ||
| Front-face fluorescence spectroscopy combined with second-order multivariate algorithms for the quantification of polyphenols in red wine samples. | Q31142792 | ||
| Bioavailability of the polyphenols: status and controversies | Q33853845 | ||
| Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. | Q33912783 | ||
| Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite | Q34108098 | ||
| Coronary artery plaque burden and calcium scores in healthy men adhering to long-term wine drinking or alcohol abstinence | Q34193160 | ||
| Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers | Q34374883 | ||
| Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies | Q34593955 | ||
| Red wine ingestion prevents microparticle formation after a single high-fat meal--a crossover study in healthy humans | Q34594471 | ||
| Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study | Q34607070 | ||
| Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study | Q35014191 | ||
| Resveratrol ameliorates high glucose and high-fat/sucrose diet-induced vascular hyperpermeability involving Cav-1/eNOS regulation | Q35445765 | ||
| Joint association of glycemic load and alcohol intake with type 2 diabetes incidence in women | Q35656436 | ||
| Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults | Q35677295 | ||
| Changes in LDL Oxidative Status and Oxidative and Inflammatory Gene Expression after Red Wine Intake in Healthy People: A Randomized Trial | Q35691489 | ||
| Higher dietary anthocyanin and flavonol intakes are associated with anti-inflammatory effects in a population of US adults | Q35781243 | ||
| Dietary flavonoids and risk of stroke in women | Q35989900 | ||
| Resveratrol, wine, and atherosclerosis | Q36238935 | ||
| High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women | Q37145881 | ||
| Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. | Q37202432 | ||
| Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms | Q37350584 | ||
| Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease | Q37445518 | ||
| Central administration of resveratrol improves diet-induced diabetes. | Q37482919 | ||
| Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid | Q37558700 | ||
| Flavonols and cardiovascular disease | Q37788333 | ||
| Flavanols and cardiovascular disease prevention | Q37790217 | ||
| Resveratrol: a cardioprotective substance | Q37831926 | ||
| Perspectives for production and application of resveratrol. | Q37848222 | ||
| Resveratrol: potential as anticancer agent | Q37995317 | ||
| High-density lipoprotein and atherosclerosis: the role of antioxidant activity | Q37996363 | ||
| Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies | Q38081384 | ||
| Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials | Q38151174 | ||
| Extraction, evolution, and sensory impact of phenolic compounds during red wine maceration | Q38178308 | ||
| Flavones: an important scaffold for medicinal chemistry | Q38229102 | ||
| Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases | Q38299279 | ||
| The role of visible and infrared spectroscopy combined with chemometrics to measure phenolic compounds in grape and wine samples. | Q38312762 | ||
| Dietary flavonoids and nitrate: effects on nitric oxide and vascular function | Q38507591 | ||
| Biochemical features of native red wines and genetic diversity of the corresponding grape varieties from Campania region | Q39346957 | ||
| Analysis of phenolics in wine by high performance thin-layer chromatography with gradient elution and high resolution plate imaging | Q40224587 | ||
| (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways | Q40676666 | ||
| Matrix-calibrated LC-MS/MS quantitation and sensory evaluation of oak Ellagitannins and their transformation products in red wines | Q43074814 | ||
| Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats | Q43265040 | ||
| Association of alcohol consumption with lipid profile in hypertensive men. | Q45022992 | ||
| White wine phenolics are absorbed and extensively metabolized in humans. | Q45091567 | ||
| Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose | Q46369936 | ||
| Dietary Anthocyanins against Obesity and Inflammation | Q47099895 | ||
| Red Wine, Resveratrol and Atrial Fibrillation | Q47118426 | ||
| Metabolism and pharmacokinetics of resveratrol and pterostilbene | Q47189418 | ||
| Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association | Q47370273 | ||
| Wine and Cardiovascular Health: A Comprehensive Review | Q47662106 | ||
| Flavonoids and Phenolic Acids from Oregano: Occurrence, Biological Activity and Health Benefits. | Q47670114 | ||
| Quantification of hydroxycinnamic derivatives in wines by UHPLC-MRM-MS. | Q48533382 | ||
| Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways. | Q49953600 | ||
| Detection of non-coloured anthocyanin-flavanol derivatives in Rioja aged red wines by liquid chromatography-mass spectrometry. | Q50224729 | ||
| Identification and quantification of 56 targeted phenols in wines, spirits, and vinegars by online solid-phase extraction - ultrahigh-performance liquid chromatography - quadrupole-orbitrap mass spectrometry | Q50277541 | ||
| Red wine intake but not other alcoholic beverages increases total antioxidant capacity and improves pro-inflammatory profile after an oral fat diet in healthy volunteers. | Q50438102 | ||
| Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. | Q50503122 | ||
| Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. | Q50504076 | ||
| Ultraviolet irradiation of trans-resveratrol and HPLC determination of trans-resveratrol and cis-resveratrol in Romanian red wines. | Q50509209 | ||
| Polyphenols in red wine aged in acacia (Robinia pseudoacacia) and oak (Quercus petraea) wood barrels. | Q50509263 | ||
| Validation of a mass spectrometry method to quantify oak ellagitannins in wine samples. | Q50518486 | ||
| Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. | Q50519099 | ||
| Identification, amounts, and kinetics of extraction of C-glucosidic ellagitannins during wine aging in oak barrels or in stainless steel tanks with oak chips. | Q50540615 | ||
| Development and validation of an analytical method for the determination of trans- and cis-resveratrol in wine: analysis of its contents in 186 Portuguese red wines. | Q50544111 | ||
| Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. | Q50595486 | ||
| Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model. | Q51756314 | ||
| Causes of death in a contemporary adult congenital heart disease cohort. | Q52318729 | ||
| Quantification of Trans-resveratrol in Red Wines Using QuEChERS Extraction Combined with Liquid Chromatography-Tandem Mass Spectrometry. | Q52324481 | ||
| Predicting the anthocyanin content of wine grapes by NIR hyperspectral imaging. | Q53380056 | ||
| Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway. | Q54392986 | ||
| Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. | Q54606528 | ||
| Effect of Natural Food Antioxidants against LDL and DNA Oxidative Changes | Q57033509 | ||
| Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial | Q57759723 | ||
| One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease | Q57759758 | ||
| Wine: An Aspiring Agent in Promoting Longevity and Preventing Chronic Diseases | Q58794809 | ||
| Controlling for high-density lipoprotein cholesterol does not affect the magnitude of the relationship between alcohol and coronary heart disease | Q82285831 | ||
| Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment | Q82686511 | ||
| Influence of growing season on phenolic compounds and antioxidant properties of grape berries from vines grown in subtropical climate | Q83206146 | ||
| Chemical and sensory evaluation of Bordeaux wines (Cabernet-Sauvignon and Merlot) and correlation with wine age | Q85297665 | ||
| Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia | Q86859993 | ||
| Dietary Guidelines for Americans | Q87042132 | ||
| Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells | Q87652097 | ||
| Antioxidant activity of resveratrol ester derivatives in food and biological model systems | Q88607555 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 19 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| wine | Q282 | ||
| alcohol consumption | Q2647488 | ||
| cardiovascular system | Q13168533 | ||
| P577 | publication date | 2019-10-08 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Red Wine Consumption and Cardiovascular Health | |
| P478 | volume | 24 |
| Q99712229 | An Industrial and Sustainable Platform for the Production of Bioactive Micronized Powders and Extracts Enriched in Polyphenols From Olea europaea L. and Vitis vinifera L. Wastes |
| Q89551762 | Analysis of Phenolic Compounds in Commercial Cannabis sativa L. Inflorescences Using UHPLC-Q-Orbitrap HRMS |
| Q92444297 | Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies |
| Q97526497 | Strategies for Reuse of Skins Separated From Grape Pomace as Ingredient of Functional Beverages |
Search more.